A Study to Look at How Safe a New Medicine (NNC0491-6075) is in Healthy People and in Participants With High Levels of Fat in the Blood

NCT05979428 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Dyslipidaemia

Interventions

DRUG: NNC0491-6075
DRUG: Placebo

Sponsor

Novo Nordisk A/S